Actively Recruiting
Clinical Utility and Outcome Prediction of Cardiovascular Computed Tomography (PREDICT-CT)
Led by Insel Gruppe AG, University Hospital Bern · Updated on 2024-10-18
4200
Participants Needed
1
Research Sites
N/A
Total Duration
On this page
Sponsors
I
Insel Gruppe AG, University Hospital Bern
Lead Sponsor
U
University Hospital, Zürich
Collaborating Sponsor
AI-Summary
What this Trial Is About
Researchers are collecting and studying information from people who undergo clinically indicated cardiovascular computed tomography angiography (CCTA) to better understand heart and blood vessel diseases. This study includes both past and future data over a period of 10 years, aiming to link imaging results, blood markers, patient details, and clinical outcomes. The goal is to predict important events like death and major heart problems in patients with coronary artery disease and related conditions. Participants in this observational study are those undergoing CCTA as part of their routine care. Investigators gather data from various sources including cardiac and non-cardiac imaging, blood tests, demographic and clinical information, and treatment changes over time. This comprehensive data collection follows a standard format to allow merging with other international registries, helping to fill knowledge gaps about cardiovascular disease. During the study, researchers review the collected data to monitor all-cause death and major adverse cardiac events over 10 years. Participants contribute by undergoing imaging and routine clinical evaluations as recommended by their doctors. The study focuses on long-term outcomes while respecting usual medical care, without altering treatments. Overall participation lasts up to a decade, with ongoing assessment of health events and therapy adjustments.
CONDITIONS
Brief Title
Clinical Utility and Outcome Prediction of Cardiovascular Computed Tomography (PREDICT-CT)
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Adult individual >18 years
- Undergoing clinically indicated CCTA
- Signed informed consent or waiver
You will not qualify if you...
- None
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Your Study Journey
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - Up to 1 day
Participants undergo clinically indicated cardiovascular computed tomography (CCTA) and related assessments to collect cross-sectional clinical and imaging data.
1 visit (in-person)
Duration - Up to 10 years
Participants are observed over a period of up to 10 years to collect longitudinal data on cardiac events, biomarker changes, and therapy modifications.
Periodic follow-up visits as per routine clinical care
Trial Site Locations
Total: 1 location
1
Department of Cardiology, University Hospital Bern, Inselspital, Bern
Bern, Switzerland, 3010
Actively Recruiting
Research Team
C
Christoph Gräni, MD, PHD
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Similar Trials
Frequently Asked Questions
Have more questions? Get in touch with our team for quick support
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here